(Q52596327)

4 May 2018

title

A novel imaging-based high-throughput screening approach to anti-angiogenic drug discovery. (English)

1 reference

4 May 2018

main subject

angiogenesis inhibitor

1 reference

1 reference

2

1 reference

4 May 2018

author name string

Lasse Evensen

series ordinal

1

1 reference

4 May 2018

Wolfgang Link

series ordinal

3

1 reference

4 May 2018

James B Lorens

series ordinal

4

1 reference

4 May 2018

publication date

1 January 2010

1 reference

4 May 2018

published in

Cytometry Part A

1 reference

4 May 2018

volume

77

1 reference

4 May 2018

issue

1

1 reference

4 May 2018

page(s)

41-51

1 reference

4 May 2018

Mural cell associated VEGF is required for organotypic vessel formation

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20808

Vinblastine suppresses dynamics of individual microtubules in living interphase cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20808

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20808

7 January 2021

Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20808

7 January 2021

Angiogenesis assays: a critical overview

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20808

7 January 2021

Automated, quantitative screening assay for antiangiogenic compounds using transgenic zebrafish

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20808

7 January 2021

In vivo models of angiogenesis

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20808

7 January 2021

In vivo target modulation and biological activity of CHIR-258, a multitargeted growth factor receptor kinase inhibitor, in colon cancer models

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20808

7 January 2021

Total synthesis of hypermodified epothilone analogs with potent in vitro antitumor activity

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20808

7 January 2021

The development of proteasome inhibitors as anticancer drugs

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20808

7 January 2021

Retroviral delivery of peptide modulators of cellular functions

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20808

7 January 2021

Improved monomeric red, orange and yellow fluorescent proteins derived from Discosoma sp. red fluorescent protein

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20808

7 January 2021

Isolation and structure of the strong cell growth and tubulin inhibitor combretastatin A-4.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20808

7 January 2021

An HTS approach to screen for antagonists of the nuclear export machinery using high content cell-based assays

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20808

7 January 2021

Localization of the vinblastine-binding site on beta-tubulin.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20808

7 January 2021

Vinblastine inhibits the angiogenic response induced by adrenomedullin in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20808

7 January 2021

Alteration of developmental program in Paramecium by treatment with trichostatin a: a possible involvement of histone modification.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20808

7 January 2021

Inhibitors of histone deacetylation downregulate the expression of endothelial nitric oxide synthase and compromise endothelial cell function in vasorelaxation and angiogenesis

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20808

7 January 2021

Histone deacetylases induce angiogenesis by negative regulation of tumor suppressor genes

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20808

7 January 2021

Histone deacetylases inhibitors as anti-angiogenic agents altering vascular endothelial growth factor signaling

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20808

7 January 2021

Thapsigargin inhibits angiogenesis in the rat isolated aorta: studies on the role of intracellular calcium pools.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20808

7 January 2021

Calmodulin inhibitor-induced apoptosis was prevented by glycogen synthase kinase-3 inhibitors in PC12 cells

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20808

7 January 2021

Alternative statistical parameter for high-throughput screening assay quality assessment

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20808

7 January 2021

Blood vessel maturation in a 3-dimensional spheroidal coculture model: direct contact with smooth muscle cells regulates endothelial cell quiescence and abrogates VEGF responsiveness.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20808

7 January 2021

Paclitaxel at ultra low concentrations inhibits angiogenesis without affecting cellular microtubule assembly

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20808

7 January 2021

Co-culture of endothelial cells and smooth muscle cells affects gene expression of angiogenic factors.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20808

7 January 2021

Angiogenesis: role of calcium-mediated signal transduction

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20808

7 January 2021

Short-term exposure to low concentrations of thapsigargin inhibits replication of cultured human vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20808

7 January 2021

Inhibition of intracellular Ca2+ mobilisation by low antiproliferative concentrations of thapsigargin in human vascular smooth-muscle cells

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20808

7 January 2021

Identifiers

DOI

10.1002/CYTO.A.20808

1 reference

4 May 2018

1 reference

4 May 2018